Officials have told Reuters that as part of the strategy the Commission will also announce plans to use an emergency 2.4-billion-euro ($2.7 billion) fund to make advance purchases of promising vaccines against the new coronavirus.
"These results support the further evaluation of BBIBP-CorV in a clinical trial", researchers said in the paper. In the U.S, a program called "Operation Warp Speed" aims to have 300 million doses on hand by January.
AS the global race to develop novel coronavirus vaccines intensifies, the pertinent question is, will countries like Malaysia get their fair share of any commercial vaccine for Covid-19.
If it works, "with this vaccine we will be able to immunize millions of Brazilians", said São Paulo´s Gov. Joao Doria.
The trials will test the vaccine on 1,045 healthy adults ages 18 to 55 years and adults 65 years and older in the United States and Belgium.
The experimental vaccine is one of five that the Trump administration has said is the most likely to succeed.
The announcement is another indication that coronavirus vaccine trials are moving ahead at a remarkable pace.
The vaccine, known as mRNA-1273, will be given in the 100 microgram dose level in the trial, which is being done in conjunction with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
No new coronavirus cases or deaths reported in Lynchburg region
Six new people have tested positive for COVID-19 as of Sunday, bringing the total to 26 positive cases in Whitman County. On Sunday the Cherokee County EMA released a statement saying now only five active cases remain.
The company has already signed deals with the U.S. government to create enough manufacturing capacity to produce more than 1 billion doses of its vaccine through 2021. He added that the company is 'working hard to bring it back to the end of the year'.
There are about 10 coronavirus vaccines in human testing.
A lot will depend on how much virus is circulating at that time, he said.
They had originally planned to begin human trials for their potential SARS-CoV-2 vaccine in September, but will now start in the second half of July.
Meanwhile, in China, employees of some large state-run companies are being given the option to get inoculated with two coronavirus vaccines now in development.
British-based drugmakers AstraZeneca AZN.L and GlaxoSmithKline GSK.L , France's Sanofi SASY.PA , and USA players Pfizer PFE.N , Novavax NVAX.O , Johnson & Johnson JNJ.N and Moderna MRNA.O are among companies trialling vaccines.
There are now about 10 coronavirus vaccines being tested in humans and experts have predicted that a safe and effective vaccine could take 12 to 18 months from the start of development.